PomDoctor Ltd. · NASDAQ:POM
PomDoctor — IPO Roadshow (August 2025)
27 slides from PomDoctor's IPO roadshow presentation, Aug 4, 2025
Slide 1: POMDOCTOR Limited Investor Presentation
POMDOCTOR LIMITED Proposed Nasdaq Ticker: POM Investor Presentation Issuer Free Writing Prospectus dated August 4 , 2025 Filed Pursuant to Rule 433 of the Securities Act of 1933 , as amended R elating to Preliminary Prospectus dated July 15 , 2025 Registration Statement No . 333 - 285771
Slide 2: Free Writing Prospectus Statement
2 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Free Writing Prospectus Statement This free writing prospectus relates to the proposed initial public
Slide 3: Forward-Looking Statements
3 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. This presentation contains forward - looking statements that reflect our current expectations and view
Slide 4: Offering Summary
4 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Offering Summary POMDOCTOR LIMITED Issuer American depositary shares (“ADS”) (Six ADSs represent one C
Slide 5: Company Overview
5 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Company Overview • We are a leading online medical services platform for chronic diseases in China . •
Slide 6: Business Model
6 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Business Model PomDoctor has established two business segments, i nternet hospital and pharmaceutical
Slide 7: Value Proposition
7 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. • Reduces the time spent on commuting • Offers one - on - one consultation with doctors • Offers conve
Slide 8: Corporate Structure
8 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. 100% 80% Corporate Structure POMDOCTOR LIMITED (Cayman Islands) POMEGRANATE CLOUD MEDICAL LIMITED (Hon
Slide 9: Internet Hospital
9 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Internet Hospital • A whole - industry - chain , one - stop comprehensive online medical services plat
Slide 10: Internet Hospital - Online consultation and prescription renewal
10 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Internet Hospital - Online consultation and prescription renewal Online Consultation Prescription Ren
Slide 11: Internet Hospital - Chronic disease management & Online drug sales
11 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Internet Hospital - Chronic disease management & Online drug sales Chronic disease management Online
Slide 12: Pharmaceutical Distribution Business
12 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Pharmaceutical Distribution Business Drug Sourcing • 639 suppliers offering 42,493 SKUs (1) • Supplie
Slide 13: Industry Overview: China Digital Health and Wellness Market
13 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. 2018 2019 2020 2021 2022 2023E 2024E 2025E 2026E 2027E Online retail pharmacy Online Consultation Onl
Slide 14: Industry Overview: Value Chain of CDM in China
14 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Industry Overview Service Provider Institutions/Companies • Platform where specialists communicate wi
Slide 15: Chronic Disease Management Market in China
15 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. 4,279.0 4,820.0 5,070.6 5,615.6 6,240.4 7,039.1 7,862.7 8,672.5 9,496.4 10,322.6 2018 2019 2020 2021
Slide 16: Investment Highlights
16 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Investment Highlights 1 Innovative and efficient one - stop online medical services platform with str
Slide 17: Innovative and Efficient One-stop Online Medical Services Platform
17 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Innovative and Efficient One - stop Online Medical Services Platform with Strong CDM Service Capabili
Slide 18: High Patient Loyalty
18 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. High Patient Loyalty Due to The Long - term Nature of Chronic Diseases and The Mutual Trust That Has
Slide 19: Well-established Pharmaceutical Supply Chain
19 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Well - established Pharmaceutical Supply Chain with A Complete Selection of Medical Products and Exte
Slide 20: Cutting-edge Platform Technology and R&D Capabilities
20 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Cutting - edge Platform Technology and Strong Research and Development Capabilities AI - empowered In
Slide 21: Experienced Management Team
21 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Experienced Management Team Led By Industry Veterans With Validation From Well - renowned Shareholder
Slide 22: Management Team and Director Appointees
22 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Zhenyang Shi Chairman, Chief Executive Officer • Ms . Jing has served as a managing director at Galax
Slide 23: Growth Strategies
23 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Growth Strategies Continue to recruit quality doctors onto our platform and attract more patient user
Slide 24: Operational Highlights
24 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Operational Highlights The Mutual Trust Between Doctors And Patients Substantial Prescriptions Scale
Slide 25: Financial Highlights: Net Revenues
25 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. Financial Highlights Net Revenues RMB in Millions 304.9 342.6 FY2023 FY2024 26.0% 74.0% 23.3% 76.7% F
Slide 26: Financial Highlights: Net Loss and Gross Profit
26 See offering documents for further risks and disclosures. There is no guarantee that any specific outcome will be achieved. I nve stments may be speculative, illiquid and there is a risk of loss. 38.7 47.7 FY2023 FY2024 Financial Highlights Note: Fiscal years ended December 31. N et L oss 36.9 37
Slide 27: Contact
Contact PomDoctor Limited Email : ir@ 7 lk . com Tel : + 86 020 - 6231 2277 Address: Yongxu Industrial Park, No.19 - 23 Hejing Road, Dongsha Street, Liwan District, Guangzhou 510000 Issuer : Joseph Stone Capital, LLC Representative of Underwriters : Email : corporatefinance@josephstonecapital . com